TXSE plans to open doors in 2026 and begin vying for new listings Dallas-based exchange hopes to reverse trend of diminishing ranks of public companies TXSE backers include BlackRock, Citadel ...

President Donald Trump’s surprise announcement that he would hike H1-B application fees to $100,000 sparked fear and confusion among foreign workers. It also sent the companies who employ them ...

The National Means cum-Merit Scholarship Scheme (NMMSS) 2025-26 has extended its last date for application submission to September 30, 2025. This scheme offers one lakh new scholarships to Class IX ...

Teachers and principals at seven persistently failing Fort Worth schools must reapply for their jobs for next school year if trustees approve a turnaround plan next week. That’s because FWISD students ...

Doug Stuart and Gordon Fee’s classic How to Read the Bible for All Its Worth taught generations of Christians how to do exegesis—discovering what a passage meant in its original context. But as I ...

Did you hear the one about the Smithsonian hiding the bones of Bible giants in the basement? No? Well, Missouri Republican Representative Eric Burlinson did, and he recently said he wants to develop a ...

A controversial new interpretation of markings etched on the walls of an ancient Egyptian mine could prove the Book of Exodus to be true. Researcher Michael Bar-Ron claimed that a 3,800-year-old Proto ...

Mr. Bronzini-Vender is a sophomore at Harvard University. The spring before I applied to college, the guidance counselors at my private school herded our mostly white grade into the gym and told us ...

The Department for Work and Pensions (DWP) has issued clarification on Personal Independence Payment (PIP) application rules after major eligibility rule changes. Clarification was issued after a ...

Deputies raided an Iowa church and removed 88 children participating in a Bible study camp as part of a sweeping human trafficking investigation, police said Monday. The youngsters are now in ...

NEW YORK, June 09, 2025 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, today ...